Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001970345 | SCV002247998 | uncertain significance | Werner syndrome | 2022-07-19 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine with valine at codon 837 of the WRN protein (p.Ile837Val). The isoleucine residue is highly conserved and there is a small physicochemical difference between isoleucine and valine. This variant is present in population databases (rs762233119, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with WRN-related conditions. ClinVar contains an entry for this variant (Variation ID: 1467191). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004970663 | SCV005533745 | uncertain significance | Inborn genetic diseases | 2024-11-12 | criteria provided, single submitter | clinical testing | The c.2509A>G (p.I837V) alteration is located in exon 21 (coding exon 20) of the WRN gene. This alteration results from a A to G substitution at nucleotide position 2509, causing the isoleucine (I) at amino acid position 837 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |